Keebeck Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.95M | Sell |
6,356
-1,373
| -18% | -$1.07M | 0.65% | 40 |
|
|
2025
Q1 | $6.38M | Buy |
7,729
+4
| +0.1% | +$3.3K | 0.94% | 21 |
|
|
2024
Q4 | $5.96M | Sell |
7,725
-421
| -5% | -$325K | 0.86% | 26 |
|
|
2024
Q3 | $7.22M | Buy |
8,146
+793
| +11% | +$703K | 1.05% | 21 |
|
|
2024
Q2 | $6.66M | Sell |
7,353
-23
| -0.3% | -$20.8K | 0.98% | 23 |
|
|
2024
Q1 | $5.74M | Sell |
7,376
-101
| -1% | -$78.6K | 0.84% | 27 |
|
|
2023
Q4 | $4.36M | Buy |
7,477
+318
| +4% | +$185K | 0.72% | 34 |
|
|
2023
Q3 | $3.85M | Sell |
7,159
-3,098
| -30% | -$1.66M | 0.67% | 41 |
|
|
2023
Q2 | $4.81M | Buy |
10,257
+1,274
| +14% | +$597K | 0.66% | 44 |
|
|
2023
Q1 | $3.08M | Buy |
8,983
+858
| +11% | +$295K | 0.5% | 54 |
|
|
2022
Q4 | $2.97M | Buy |
8,125
+366
| +5% | +$134K | 0.52% | 51 |
|
|
2022
Q3 | $2.51M | Buy |
7,759
+941
| +14% | +$304K | 0.48% | 51 |
|
|
2022
Q2 | $2.21M | Buy |
6,818
+882
| +15% | +$286K | 0.42% | 60 |
|
|
2022
Q1 | $1.7M | Buy |
5,936
+617
| +12% | +$177K | 0.28% | 86 |
|
|
2021
Q4 | $1.47M | Buy |
5,319
+300
| +6% | +$82.9K | 0.26% | 85 |
|
|
2021
Q3 | $1.16M | Sell |
5,019
-311
| -6% | -$71.9K | 0.23% | 93 |
|
|
2021
Q2 | $1.22M | Buy |
5,330
+542
| +11% | +$124K | 0.18% | 103 |
|
|
2021
Q1 | $895K | Buy |
4,788
+115
| +2% | +$21.5K | 0.14% | 118 |
|
|
2020
Q4 | $789K | Buy |
4,673
+153
| +3% | +$25.8K | 0.14% | 118 |
|
|
2020
Q3 | $668K | Buy |
4,520
+625
| +16% | +$92.4K | 0.14% | 112 |
|
|
2020
Q2 | $638K | Buy |
3,895
+1,718
| +79% | +$281K | 0.2% | 94 |
|
|
2020
Q1 | $301K | Sell |
2,177
-23
| -1% | -$3.18K | 0.13% | 121 |
|
|
2019
Q4 | $288K | Buy |
+2,200
| New | +$288K | 0.09% | 120 |
|